Sectors

INVA
Innoviva, Inc.
21.51
1 x 21.43
1 x 21.44
bid
ask
-
0.07
0.32%
11:11 AM
timesize
Ytd7.60%
1y11.57%
21.44
day range
21.70
16.52
52 week range
25.15
Open21.68Prev Close21.58Low21.44High21.70Mkt Cap1.59B
Vol76.80KAvg Vol826.05KEPS4.23P/E5.10Forward P/E11.07
Beta0.34Short Ratio7.09Inst. Own108.03%DividendN/ADiv YieldN/A
Ex Div Date09-08Earning08-0550-d Avg22.35200-d Avg21.361yr Est35.50

INVA News

Nortiva Bio Launches to Develop Long-Acting Oral Medicines
gurufocus.com
Nortiva Bio Launches to Develop Long-Acting Oral Medicines

Nortiva Bio, Inc. (“Nortiva”) today announced its launch as a clinical-stage biopharmaceutical c

Nortiva Bio Launches to Develop Long-Acting Oral Medicines
businesswire.com
Nortiva Bio Launches to Develop Long-Acting Oral Medicines

LEXINGTON, Mass.--(BUSINESS WIRE)--Nortiva Bio, Inc. (“Nortiva”) today announced its launch as a cli

Innoviva Specialty Therapeutics Announces Distribution and Licensing Agreement with Dr. Reddy's for XACDURO® in Select International Markets
businesswire.com
Innoviva Specialty Therapeutics Announces Distribution and Licensing Agreement with Dr. Reddy's for

WALTHAM, Mass.--(BUSINESS WIRE)--Innoviva Specialty Therapeutics, a subsidiary of Innoviva, Inc. (Na

Innoviva, Inc. (INVA) Presents at Goldman Sachs 47th Annual Global Healthcare Conference 2026 Transcript
seekingalpha.com
Innoviva, Inc. (INVA) Presents at Goldman Sachs 47th Annual Global Healthcare Conference 2026 Transc

Innoviva, Inc. (INVA) Presents at Goldman Sachs 47th Annual Global Healthcare Conference 2026 Transc

Innoviva to Participate in Upcoming Investor Conferences
gurufocus.com
Innoviva to Participate in Upcoming Investor Conferences

Innoviva, Inc. (NASDAQ: INVA) (“Innoviva” or the “Company”), a diversified biopharmaceutical

Innoviva to Participate in Upcoming Investor Conferences
businesswire.com
Innoviva to Participate in Upcoming Investor Conferences

BURLINGAME, Calif.--(BUSINESS WIRE)--Innoviva, Inc. (NASDAQ: INVA) (“Innoviva” or the “Company”), a

Innoviva Stock Is Up Just 10% This Past Year. Here's Why a Fund Bought $2.5 Million More
fool.com
Innoviva Stock Is Up Just 10% This Past Year. Here's Why a Fund Bought $2.5 Million More

Innoviva develops respiratory pharmaceuticals through strategic partnerships and royalty agreements

Innoviva (INVA) Tops Q1 Earnings Estimates
zacks.com
Innoviva (INVA) Tops Q1 Earnings Estimates

Innoviva (INVA) came out with quarterly earnings of $0.44 per share, beating the Zacks Consensus Est

Earnings Scheduled For May 6, 2026
benzinga.com
Earnings Scheduled For May 6, 2026

Innoviva Reports First Quarter 2026 Financial Results; Highlights Recent Company Progress
businesswire.com
Innoviva Reports First Quarter 2026 Financial Results; Highlights Recent Company Progress

BURLINGAME, Calif.--(BUSINESS WIRE)--Innoviva, Inc. (NASDAQ: INVA) (“Innoviva” or the “Company”), a

Merck (MRK) Reports Q1 Loss, Tops Revenue Estimates
zacks.com
Merck (MRK) Reports Q1 Loss, Tops Revenue Estimates

Merck (MRK) came out with a quarterly loss of $1.28 per share versus the Zacks Consensus Estimate of

Innoviva, Inc. (NASDAQ:INVA) Given Consensus Recommendation of “Moderate Buy” by Brokerages
defenseworld.net
Innoviva, Inc. (NASDAQ:INVA) Given Consensus Recommendation of “Moderate Buy” by Brokerages

Shares of Innoviva, Inc. (NASDAQ: INVA - Get Free Report) have been assigned a consensus rating of "

3 Bargain-Cheap Small Caps Worth a Second Look
marketbeat.com
3 Bargain-Cheap Small Caps Worth a Second Look

The price-to-earnings (P/E) ratio is a commonly used metric that provides a snapshot of a company's

Innoviva (NASDAQ:INVA) Shares Cross Above 200 Day Moving Average   – Here’s What Happened
defenseworld.net
Innoviva (NASDAQ:INVA) Shares Cross Above 200 Day Moving Average – Here’s What Happened

Innoviva, Inc. (NASDAQ: INVA - Get Free Report)'s stock price passed above its two hundred day movin

Analysts Set Innoviva, Inc. (NASDAQ:INVA) Price Target at $34.80
defenseworld.net
Analysts Set Innoviva, Inc. (NASDAQ:INVA) Price Target at $34.80

Shares of Innoviva, Inc. (NASDAQ: INVA - Get Free Report) have earned a consensus rating of "Moderat

Innoviva Specialty Therapeutics Earns Strong Performance Rating in Access to Medicine Foundation's 2026 Antimicrobial Resistance Benchmark Report
businesswire.com
Innoviva Specialty Therapeutics Earns Strong Performance Rating in Access to Medicine Foundation's 2

WALTHAM, Mass.--(BUSINESS WIRE)--Innoviva Specialty Therapeutics, a subsidiary of Innoviva Inc., tod

Innoviva, Inc. (INVA) Presents at Oppenheimer 36th Annual Healthcare Life Sciences Conference Transcript
seekingalpha.com
Innoviva, Inc. (INVA) Presents at Oppenheimer 36th Annual Healthcare Life Sciences Conference Transc

Innoviva, Inc. (INVA) Presents at Oppenheimer 36th Annual Healthcare Life Sciences Conference Transc

Innoviva, Inc. (NASDAQ:INVA) Receives Average Recommendation of “Moderate Buy” from Brokerages
defenseworld.net
Innoviva, Inc. (NASDAQ:INVA) Receives Average Recommendation of “Moderate Buy” from Brokerages

Innoviva, Inc. (NASDAQ: INVA - Get Free Report) has been given an average recommendation of "Moderat

Innoviva Reports Fourth Quarter and Full Year 2025 Financial Results; Highlights Recent Company Progress
businesswire.com
Innoviva Reports Fourth Quarter and Full Year 2025 Financial Results; Highlights Recent Company Prog

BURLINGAME, Calif.--(BUSINESS WIRE)--Innoviva, Inc. (NASDAQ: INVA) (“Innoviva” or the “Company”), a

Innoviva to Participate in the Oppenheimer 36th Annual Healthcare Life Sciences Conference
businesswire.com
Innoviva to Participate in the Oppenheimer 36th Annual Healthcare Life Sciences Conference

BURLINGAME, Calif.--(BUSINESS WIRE)--Innoviva, Inc. (NASDAQ: INVA) (“Innoviva” or the “Company”), a

SG Americas Securities LLC Raises Position in Innoviva, Inc. $INVA
defenseworld.net
SG Americas Securities LLC Raises Position in Innoviva, Inc. $INVA

SG Americas Securities LLC grew its position in shares of Innoviva, Inc. (NASDAQ: INVA) by 134.4% du

benzinga.com
Stocks That Hit 52-Week Lows On Thursday

  On Thursday, 1076 companies hit new 52-week lows.

benzinga.com
Stocks That Hit 52-Week Lows On Wednesday

Stocks That Hit 52-Week Lows On Wednesday

benzinga.com
Stocks That Hit 52-Week Lows On Monday

Stocks That Hit 52-Week Lows On Monday